Related references
Note: Only part of the references are listed.The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review
Ami D. Sperber et al.
GUT (2017)
A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial
Heidi Maria Staudacher et al.
GASTROENTEROLOGY (2017)
Irritable bowel syndrome: a gut microbiota-related disorder?
Yogesh Bhattarai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)
Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease
Y. Derwa et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates
Doris Vandeputte et al.
GUT (2016)
Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3
Eun-ju Do et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut
Audrey Riviere et al.
FRONTIERS IN MICROBIOLOGY (2016)
Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment
Jayashree Dolpady et al.
JOURNAL OF DIABETES RESEARCH (2016)
Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut
Henrik M. Roager et al.
NATURE MICROBIOLOGY (2016)
Melatonin Regulation as a Possible Mechanism for Probiotic (VSL#3) in Irritable Bowel Syndrome: A Randomized Double-Blinded Placebo Study
Reuben K. Wong et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
American Gastroenterological Association Institute Technical Review on the Pharmacological Management of Irritable Bowel Syndrome
Lin Chang et al.
GASTROENTEROLOGY (2014)
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Magnus Simren et al.
GUT (2013)
VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-κB pathway in rat model of DSS-induced colitis
Cong Dai et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Probiotics VSL#3 Protect against Development of Visceral Pain in Murine Model of Irritable Bowel Syndrome
Eleonora Distrutti et al.
PLOS ONE (2013)
Gut Microbiota is Not Modified by Randomized, Double-Blind, Placebo-Controlled Trial of VSL#3 in Diarrhea-Predominant Irritable Bowel Syndrome
Sonia Michail et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
VSL#3 Improves Symptoms in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Crossover Study
Stefano Guandalini et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2010)
Gastrointestinal microbiota in irritable bowel syndrome: Their role in its pathogenesis and treatment
Gareth C. Parkes et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating
HJ Kim et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
An irritable bowel syndrome-specific symptom questionnaire: Development and validation
IK Wiklund et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome
HJ Kim et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Probiotic bacteria enhance murine and human intestinal epithelial barrier function
K Madsen et al.
GASTROENTEROLOGY (2001)
Share Paper
